Objectives To evaluate the virological response and to describe the resistance profiles in the
case of failure after 6 months of first-line highly active antiretroviral therapy (HAART) in HIV-1 …

Abstract A total of 242 HIV-1-infected children were followed up at the Complexe Pédiatrique
of Bangui, Central African Republic, including 165 receiving antiretroviral treatment in first …

Introduction In recent years, children born to HIV-infected mothers have been receiving
antiretroviral treatment (ART) with limited or no virologic monitoring, which increases the …

Objectives To assess long-term virological efficacy and the emergence of drug resistance in
children who receive antiretroviral treatment (ART) in rural Tanzania. Patients and methods …

Background Early recognition of antiretroviral therapy (ART) failure in resource limited
settings is a challenge given the limited laboratory facilities and trained personnel. This …

Background Pretreatment HIV drug resistance (PDR) can impair virological response to
ART, jeopardizing effective treatment for children. Methods Children aged≤ 12 years …

Background: Nonnucleoside reverse transcription inhibitor (NNRTI)-based antiretroviral
therapy (ART) has been widely used as a first-line regimen for the treatment of HIV. This …

Objective: To estimate the frequency of human immunodeficiency virus type 1 (HIV-1)
displaying genotypic drug resistance in highly active antiretroviral therapy (HAART)-treated …

Objectives The aim of the study was to assess the prevalence, predictors and patterns of
genotypic resistance mutations in children after failure of World Health Organization …

A large cohort of 220 HIV-1-infected children (median [range] age: 12 [4–17] years) was
cared and followed up in the Central African Republic, including 198 in 1st-line and 22 in …